Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
An update on a clinical trial aimed at characterizing the immunogenicity of TNF inhibitors in arthritis patients with poorer treatment respo…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis [NA]
A clinical trial is recruiting to study the effects of a partial enteral nutrition diet on immune responses and gut microbiota in axial spon…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
Clinical trial SAPHIR assesses predictive factors for persistence of adalimumab treatment after switching from reference product to Freseniu…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Fecal Microbiota Transplantation in Axial Spondyloarthritis [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for axial spondyloarthritis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis [Phase 2, Phase 3]
Clinical trial update reports efficacy and safety data for SHR-1314 in patients with active ankylosing spondylitis across Phase 2 and Phase …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
The study examining the colonic microbiome and mucosal immunity in inflammatory bowel disease and ankylosing spondylitis is currently active…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
A completed clinical trial in Sweden evaluated the safety of etoricoxib (MK-0663) in patients with spondyloarthropathies, including ankylosi…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study of CC-99677 in Participants With Active Ankylosing Spondylitis [Phase 2]
A Phase 2 trial of CC-99677 in active ankylosing spondylitis was terminated, with results posted.
-
FDA approval · 2024-04-30FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for ABRILADA (adalimumab-afzb) from Pfizer Laboratories Div Pfizer Inc, authorizing its use as a…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Telerehabilitation in Ankylosing Spondylitis [NA]
An ongoing clinical trial at Firat University is evaluating telerehabilitation for Ankylosing Spondylitis and is currently recruiting.
-
FDA approval · 2024-04-26FDA Approved: RINVOQ — Original Application (AbbVie Inc.)
The FDA approved Rinvoq (upadacitinib) from AbbVie under an Original Application NDA, granting the drug its initial US marketing authorizati…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Korean College of Rheumatology Biologics and Targeted Therapy Registry
A registry study in Korea tracking biologics and targeted therapies for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthriti…
-
FDA approval · 2024-03-29FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for the generic Diclofenac Sodium/Misoprostol product from Micro Labs Limited, authorizing its marke…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial evaluating efficacy and safety of AK111 in active Ankylosing Spondylitis has completed.
-
FDA approval · 2024-02-22FDA Approved: ZYMFENTRA — Supplemental Application (CELLTRION USA Inc.)
The FDA approved a supplemental application for ZYMFENTRA (infliximab-dyyb) submitted by Celltrion USA Inc.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Clinical Study of JS005 in Patients With Ankylosing Spondylitis [Phase 2]
A Phase 2 clinical trial update for JS005 in patients with Ankylosing Spondylitis.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA [Phase 3]
A Phase 3 study comparing an intravenous regimen of secukinumab to placebo in adults with active axial spondyloarthritis (ankylosing spondyl…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis [Phase 2]
Phase II trial of Hemay005 in active ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS) [Phase 3]
Extension study update for Jaktinib in active Ankylosing Spondylitis in Phase 3.
-
FDA approval · 2023-12-26FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Renflexis (infliximab) submitted by Organon LLC.
-
FDA approval · 2023-12-15FDA Approved: HULIO — Supplemental Application (Biocon Biologics Inc)
The FDA approved a supplemental application for HULIO, Biocon Biologics' biosimilar adalimumab (adalimumab-fkJP).
-
FDA approval · 2023-11-30FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
The FDA approved a supplemental Biologics License Application for the adalimumab biosimilar ADALIMUMAB-AATY from Celltrion USA, Inc., allowi…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 trial comparing meloxicam suppository and tablet to indomethacin suppository for efficacy and safety in ankylosing spondylitis has c…
-
FDA approval · 2023-11-20FDA Tentative Approval: TALTZ — Supplemental Application (Eli Lilly and Company)
The FDA issued tentative approval for a supplemental application for TALTZ (ixekizumab) by Eli Lilly, indicating the submission is approvabl…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients [Phase 4]
Phase 4 clinical trial update evaluating clinical efficacy and immune cell subset changes with bioagents in ankylosing spondylitis.